The Basis for the Distinct Biological Activities of Vascular Endothelial Growth Factor Receptor-1 Ligands

被引:46
作者
Anisimov, Andrey [1 ,2 ]
Leppanen, Veli-Matti [3 ]
Tvorogov, Denis [1 ,2 ]
Zarkada, Georgia [1 ,2 ,3 ]
Jeltsch, Michael [1 ,2 ,3 ]
Holopainen, Tanja [1 ,2 ]
Kaijalainen, Seppo [1 ,2 ]
Alitalo, Kari [1 ,2 ,3 ]
机构
[1] Univ Helsinki, Biomedicum Helsinki, Translat Canc Biol Program, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Univ Helsinki Cent Hosp, FIN-00014 Helsinki, Finland
[3] Biomedicum Helsinki, Wihuri Res Inst, FIN-00290 Helsinki, Finland
基金
欧洲研究理事会; 芬兰科学院;
关键词
IMMUNOGLOBULIN-LIKE DOMAIN; FACTOR VEGF FAMILY; FACTOR-B; SIGNAL-TRANSDUCTION; PATHOLOGICAL ANGIOGENESIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING; KINASE; ACTIVATION;
D O I
10.1126/scisignal.2003905
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factors (VEGFs) regulate blood and lymphatic vessel development through VEGF receptors (VEGFRs). The VEGFR immunoglobulin homology domain 2 (D2) is critical for ligand binding, and D3 provides additional interaction sites. VEGF-B and placenta growth factor (PlGF) bind to VEGFR-1 with high affinity, but only PlGF is angiogenic in most tissues. We show that VEGF-B, unlike other VEGFs, did not require D3 interactions for high-affinity binding. VEGF-B with a PlGF-derived L1 loop (B-L1(P)) stimulated VEGFR-1 activity, whereas PlGF with a VEGF-B-derived L1 loop (P-L1(B)) did not. Unlike P-L1(B) and VEGF-B, B-L1(P) and PlGF were also angiogenic in mouse skeletal muscle. Furthermore, B-L1(P) also bound to VEGFR-2 and activated downstream signaling. These results establish a role for L1-mediated D3 interactions in VEGFR activation in endothelial cells and indicate that VEGF-B is a high-affinity VEGFR-1 ligand that, unlike PlGF, cannot efficiently induce signaling downstream of VEGFR-1.
引用
收藏
页数:10
相关论文
共 58 条
[1]   Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect [J].
Aase, K ;
von Euler, G ;
Li, X ;
Pontén, A ;
Thorén, P ;
Cao, R ;
Cao, Y ;
Olofsson, B ;
Gebre-Medhin, S ;
Pekny, M ;
Alitalo, K ;
Betsholtz, C ;
Eriksson, U .
CIRCULATION, 2001, 104 (03) :358-364
[2]   Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3 [J].
Achen, MG ;
Roufail, S ;
Domagala, T ;
Catimel, B ;
Nice, EC ;
Geleick, DM ;
Murphy, R ;
Scott, AM ;
Caesar, C ;
Makinen, T ;
Alitalo, K ;
Stacker, SA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (09) :2505-2515
[3]   Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis [J].
Albrecht, Imke ;
Kopfstein, Lucie ;
Strittmatter, Karin ;
Schomber, Tibor ;
Falkevall, Annelie ;
Hagberg, Carolina E. ;
Lorentz, Pascal ;
Jeltsch, Michael ;
Alitalo, Kari ;
Eriksson, Ulf ;
Christofori, Gerhard ;
Pietras, Kristian .
PLOS ONE, 2010, 5 (11)
[4]   Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle [J].
Anisimov, Andrey ;
Alitalo, Annamari ;
Korpisalo, Petra ;
Soronen, Jarkko ;
Kaijalainen, Seppo ;
Leppanen, Veli-Matti ;
Jeltsch, Michael ;
Yla-Herttuala, Seppo ;
Alitalo, Kari .
CIRCULATION RESEARCH, 2009, 104 (11) :1302-U156
[5]  
[Anonymous], 2007, CELL, V131, P463
[6]   Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 [J].
Autiero, M ;
Waltenberger, J ;
Communi, D ;
Kranz, A ;
Moons, L ;
Lambrechts, D ;
Kroll, J ;
Plaisance, S ;
De Mol, M ;
Bono, F ;
Kliche, S ;
Fellbrich, G ;
Ballmer-Hofer, K ;
Maglione, D ;
Mayr-Beyrle, U ;
Dewerchin, M ;
Dombrowski, S ;
Stanimirovic, D ;
Van Hummelen, P ;
Dehio, C ;
Hicklin, DJ ;
Persico, G ;
Herbert, JM ;
Communi, D ;
Shibuya, M ;
Collen, D ;
Conway, EM ;
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (07) :936-943
[7]   PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth [J].
Bais, Carlos ;
Wu, Xiumin ;
Yao, Jenny ;
Yang, Suya ;
Crawford, Yongping ;
McCutcheon, Krista ;
Tan, Christine ;
Kolumam, Ganesh ;
Vernes, Jean-Michel ;
Eastham-Anderson, Jeffrey ;
Haughney, Peter ;
Kowanetz, Marcin ;
Hagenbeek, Thijs ;
Kasman, Ian ;
Reslan, Hani Bou ;
Ross, Jed ;
Van Bruggen, Nick ;
Carano, Richard A. D. ;
Meng, Yu-Ju Gloria ;
Hongo, Jo-Anne ;
Stephan, Jean-Philippe ;
Shibuya, Masabumi ;
Ferrara, Napoleone .
CELL, 2010, 141 (01) :166-177
[8]   Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia [J].
Bellomo, D ;
Headrick, JP ;
Silins, GU ;
Paterson, CA ;
Thomas, PS ;
Gartside, M ;
Mould, A ;
Cahill, MM ;
Tonks, ID ;
Grimmond, SM ;
Townson, S ;
Wells, C ;
Little, M ;
Cummings, MC ;
Hayward, NK ;
Kay, GF .
CIRCULATION RESEARCH, 2000, 86 (02) :E29-E35
[9]   Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization [J].
Brozzo, Maurice S. ;
Bjelic, Sasa ;
Kisko, Kaisa ;
Schleier, Thomas ;
Leppanen, Veli-Matti ;
Alitalo, Kari ;
Winkler, Fritz K. ;
Ballmer-Hofer, Kurt .
BLOOD, 2012, 119 (07) :1781-1788
[10]   Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation [J].
Bry, Maija ;
Kivela, Riikka ;
Holopainen, Tanja ;
Anisimov, Andrey ;
Tammela, Tuomas ;
Soronen, Jarkko ;
Silvola, Johanna ;
Saraste, Antti ;
Jeltsch, Michael ;
Korpisalo, Petra ;
Carmeliet, Peter ;
Lemstrom, Karl B. ;
Shibuya, Masabumi ;
Yla-Herttuala, Seppo ;
Alhonen, Leena ;
Mervaala, Eero ;
Andersson, Leif C. ;
Knuuti, Juhani ;
Alitalo, Kari .
CIRCULATION, 2010, 122 (17) :1725-1733